Chemoinformaics analysis of Dalspinin-7-O-beta-D-galactopyranoside
| Molecular Weight | 490.417 | nRot | 5 |
| Heavy Atom Molecular Weight | 468.241 | nRig | 28 |
| Exact Molecular Weight | 490.111 | nRing | 5 |
| Solubility: LogS | -4.081 | nHRing | 3 |
| Solubility: LogP | 0.068 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 57 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 2 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 17 |
| nHA | 12 | APOL | 62.7034 |
| nHD | 5 | BPOL | 33.3546 |
| QED | 0.326 |
| Synth | 4.049 |
| Natural Product Likeliness | 1.826 |
| NR-PPAR-gamma | 0.874 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.832 |
| HIA | 0.028 |
| CACO-2 | -6.1 |
| MDCK | 0.00003 |
| BBB | 0.13 |
| PPB | 0.780198 |
| VDSS | 0.804 |
| FU | 0.156994 |
| CYP1A2-inh | 0.044 |
| CYP1A2-sub | 0.297 |
| CYP2c19-inh | 0.023 |
| CYP2c19-sub | 0.097 |
| CYP2c9-inh | 0.012 |
| CYP2c9-sub | 0.35 |
| CYP2d6-inh | 0.347 |
| CYP2d6-sub | 0.226 |
| CYP3a4-inh | 0.515 |
| CYP3a4-sub | 0.034 |
| CL | 2.936 |
| T12 | 0.21 |
| hERG | 0.051 |
| Ames | 0.422 |
| ROA | 0.113 |
| SkinSen | 0.041 |
| Carcinogencity | 0.808 |
| EI | 0.008 |
| Respiratory | 0.023 |
| NR-Aromatase | 0.271 |
| Antiviral | Yes |
| Prediction | 0.830319 |